Gesamtlänge aller Episoden: 21 hours 48 minutes
As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. To mark World TB Day, chief editor Martin Kolb interviews section editor Giovanni Battista Migliori about the following articles. Borisov SE, Dheda K, Enwerem M, et al. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur Respir J 2017; 49: 1700387. Cabibbe AM, Sotgiu G, Izco S, et al. Genotypic and phenotypic M...
As part of the February issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Martin Kolb interviews the Jørgen Vestbo (The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK) about the important difference between standard efficacy trials and real-world effectiveness trials such as the Salford Lung Study.
As part of the December issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert interviews the incoming Chief Editor Martin Kolb and Deputy Chief Editor James Chalmers about the future of the ERJ, and reflects on his own time as Chief Editor.
As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the ERS statement on the diagnosis and treatment of pulmonary disease caused by α1-antitrypsin deficiency with Task Force chairs Marc Miravitlles (Hospital Universitari Vall d'Hebron, Barcelona, Spain) and Robert A. Stockley (Queen Elizabeth Hospital, Birmingham, UK).
As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the lessons learned from clinical trials in idiopathic pulmonary fibrosis over the past 25 years with Prof. Ganesh Raghu from the University of Washington, Seattle, WA, USA.
As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of the results of a survey of patients with severe asthma with Prof. Helen K. Reddel from the University of Sydney, Sydney, and the NHMRC Centre for Research Excellence in Severe Asthma, Newcastle, Australia.
As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of the results of a trial of fevipiprant, an oral prostaglandin in DP2 receptor (CRTh2) antagonist, in allergic asthma that is not controlled by low-dose inhaled corticosteroids with Prof. Eric D. Bateman from the University of Cape Town, South Africa.
As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of the results of a prospective cohort study of the risk of recurrent venous thromboembolism in COPD patients with Prof. Francis Couturaud from Hôpital La Cavale Blanche and Université Européenne de Bretagne, Brest, France.
As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of an original article on chronic pulmonary aspergillosis in advanced pulmonary sarcoidosis with Prof. David Denning from the National Aspergillosis Centre at the University Hospital of South Manchester and the University of Manchester, UK.
As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. On the occasion of World TB Day 2017, chief editor Marc Humbert discusses the publication of a number of new articles on tuberculosis with Prof. G.B. Migliori from the Fondazione S. Maugeri Care and Research Institute, Italy.